External validation of a nomogram predicting the probability of prostate cancer gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients

Urology

Volumn 76, Issue 2, 2010, Pages 404-410

  Imamoto, Takashi ^a   Suzuki, Hiroyoshi ^a   Utsumi, Takanobu ^a   Takano, Makoto ^a   Suyama, Takahito ^a   Kawamura, Koji ^a   Kamiya, Naoto ^a   Naya, Yukio ^a   Ueda, Takeshi ^a   Ichikawa, Tomohiko ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; GLEASON SCORE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; TUMOR BIOPSY;

AGED; BIOPSY; HUMANS; JAPAN; MALE; MIDDLE AGED; NOMOGRAMS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 77955708349     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.05.084     Document Type: Article

References (26)

1. A.V. D'Amico, R. Whittington, and S.B. Malkowicz A multivariate analysis of clinical and pathological factors which predict for prostate-specific antigen failure after radical prostatectomy for prostate cancer J Urol 154 1995 131 138
2. P.A. Humphrey, H.A. Frazier, and R.T. Vollmer Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate specific antigen levels Cancer 71 1993 1821 1827
3. H. Zincke, E.J. Bergstralh, and M.L. Blute Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution J Clin Oncol 12 1994 2254 2263
4. P. Narayan, V. Gajendran, and S.P. Taylor The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer Urology 46 1995 205 212
5. A.W. Partin, J. Yoo, and H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110 114 (Pubitemid 23175983)
6. C.R. King, and J.P. Long Prostate biopsy grading errors: a sampling problem? Int J Cancer 90 2000 326 330
7. C.R. King Patterns of prostate cancer biopsy grading: trends and clinical implications Int J Cancer 90 2000 305 311
8. K. Cam, S. Yucel, and L. Turkeri Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens Int J Urol 9 2002 257 260
9. F.K. Chun, T. Steuber, and A. Erbersdobler Development and 134 internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology Eur Urol 49 2006 820 826
10. G.S. Kulkarni, G. Lockwood, and A. Evans Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy Cancer 109 2007 2432 2438
11. A.V. D'Amico, A.A. Renshaw, and L. Arsenault Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy Int J Radiat Oncol Biol Phys 45 1999 841 846
12. G. Aus, C.C. Abbou, and M. Bolla EAU guidelines on prostate cancer Eur Urol 48 2005 546 551
13. T. Imamoto, H. Suzuki, and S. Fukasawa Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy Eur Urol 47 2005 308 312
14. M. Yano, T. Imamoto, and H. Suzuki The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening Eur Urol 51 2007 293 295
15. C.R. King, J.E. McNeal, and H. Gill Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients Int J Radiat Oncol Biol Phys 59 2004 386 391
16. S. Roemeling, M.J. Roobol, and S.H. de Vries Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome Eur Urol 51 2007 1244 1250
17. C.R. King, D.A. Patel, and M.K. Terris Prostate biopsy volume indices do not predict for significant Gleason upgrading Am J Clin Oncol 28 2005 125 129
18. M. Inahara, H. Suzuki, and S. Kojima Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings Urology 68 2006 815 819
19. H. Suzuki, N. Kamiya, and T. Imamoto Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients Urology 67 2006 131 136
20. F.K. Chun, A. Briganti, and S.F. Shariat Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation BJU Int 98 2006 329 334
21. M.W. Kattan, S.F. Shariat, and B. Andrews The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer J Clin Oncol 21 2003 3573 3579
22. T. Imamoto, H. Suzuki, and M. Yano The role of testosterone in the pathogenesis of prostate cancer Int J Urol 15 2008 472 480
23. H. Suzuki, A. Komiya, and S. Aida Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer Prostate 28 1996 318 324
24. R.K. Ross, M.C. Pike, and G.A. Coetzee Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility Cancer Res 58 1998 4497 4504
25. T. Imamoto, H. Suzuki, and M. Yano Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients? Prostate Cancer Prostatic Dis 12 2009 78 82
26. R.K. Ross, L. Bernstein, and R.A. Lobo 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males Lancet 339 1992 887 889